Neurology. 2007 Nov 13;69(20):1942-52.

Guidelines for using proton MR spectroscopy in multicenter clinical MS studies.

De Stefano N, Filippi M, Miller D, Pouwels PJ, Rovira A, Gass A, Enzinger C, Matthews PM, Arnold DL.

Source

Department of Neurological and Behavioral Sciences, University of Siena, Viale Bracci 2, 53100 Siena, Italy. destefano@unisi.it

Abstract

Proton MR spectroscopy (MRS) allows noninvasive characterization of chemical-pathologic changes in the brain. In patients with multiple sclerosis (MS), proton MRS reveals chemical pathology in focal inflammatory lesions as well as in regions of the brain that are not associated with structural abnormalities on conventional MRI. In MS studies, it has been particularly useful as a method for the assessment of neurodegeneration based on decreases in the levels of the neuro-axonal marker compound, N-acetylaspartate. Also, MRS has provided evidence of chemical pathology and repair involving non-neuronal brain cells based on changes in metabolites, including choline, myo-inositol, glutamate, and GABA. Despite its greater pathologic specificity for axonal integrity compared to conventional MRI, MRS has been used only infrequently in clinical trials. This prompted us to review current MRS clinical applications in MS, discuss the potential and limitations of the technique, and suggest recommendations for the application of MRS to clinical trials.

PMID:: 17998486; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Review

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Education

New England Research Institutes Inc.

Medical

Multiple Sclerosis - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Review MR spectroscopy in multiple sclerosis. [J Neuroimaging. 2007]
Review MR spectroscopy in multiple sclerosis.
De Stefano N, Filippi M. J Neuroimaging. 2007 Apr; 17 Suppl 1:31S-35S.
Review Role of magnetic resonance spectroscopy in diagnosis and management of multiple sclerosis. [Neurol Res. 2006]
Review Role of magnetic resonance spectroscopy in diagnosis and management of multiple sclerosis.
Gonzalez-Toledo E, Kelley RE, Minagar A. Neurol Res. 2006 Apr; 28(3):280-3.
Review Proton magnetic resonance spectroscopy of the brain in dementia. [Ital J Neurol Sci. 1999]
Review Proton magnetic resonance spectroscopy of the brain in dementia.
De Stefano N, Mortilla M, Federico A. Ital J Neurol Sci. 1999; 20(5 Suppl):S258-64.
Review The contribution of (1)H-magnetic resonance spectroscopy in defining the pathophysiology of multiple sclerosis. [Ital J Neurol Sci. 1999]
Review The contribution of (1)H-magnetic resonance spectroscopy in defining the pathophysiology of multiple sclerosis.
Simone IL, Tortorella C, Federico F. Ital J Neurol Sci. 1999; 20(5 Suppl):S241-5.
Review Magnetic resonance spectroscopy as a measure of brain damage in multiple sclerosis. [J Neurol Sci. 2005]
Review Magnetic resonance spectroscopy as a measure of brain damage in multiple sclerosis.
De Stefano N, Bartolozzi ML, Guidi L, Stromillo ML, Federico A. J Neurol Sci. 2005 Jun 15; 233(1-2):203-8. Epub 2005 Apr 20.

See reviews... See all...

Cited by 10 PubMed Central articles

Review Progressive multiple sclerosis and gray matter pathology: an MRI perspective. [Mt Sinai J Med. 2011]
Review Progressive multiple sclerosis and gray matter pathology: an MRI perspective.
Inglese M, Oesingmann N, Casaccia P, Fleysher L. Mt Sinai J Med. 2011 Mar-Apr; 78(2):258-67.
Review Neuroimaging in multiple sclerosis: neurotherapeutic implications. [Neurotherapeutics. 2011]
Review Neuroimaging in multiple sclerosis: neurotherapeutic implications.
Sicotte NL. Neurotherapeutics. 2011 Jan; 8(1):54-62.
Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis. [Brain. 2010]
Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis.
Baranzini SE, Srinivasan R, Khankhanian P, Okuda DT, Nelson SJ, Matthews PM, Hauser SL, Oksenberg JR, Pelletier D. Brain. 2010 Sep; 133(9):2603-11.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Guidelines for using proton MR spectroscopy in multicenter clinical MS studies.
Guidelines for using proton MR spectroscopy in multicenter clinical MS studies.
Neurology. 2007 Nov 13 ;69(20):1942-52.

PubMed
Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of...
Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function.
Circulation. 2007 Nov 13 ;116(20):2325-45.

PubMed
Dopamine in drug abuse and addiction: results of imaging studies and treatment i...
Dopamine in drug abuse and addiction: results of imaging studies and treatment implications.
Arch Neurol. 2007 Nov ;64(11):1575-9.

PubMed
Candidate single-nucleotide polymorphisms from a genomewide association study of...
Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease.
Arch Neurol. 2008 Jan ;65(1):45-53. Epub 2007 Nov 12 .

PubMed
Phosphoinositide 3-kinase gamma participates in T cell receptor-induced T cell a...
Phosphoinositide 3-kinase gamma participates in T cell receptor-induced T cell activation.
J Exp Med. 2007 Nov 26 ;204(12):2977-87. Epub 2007 Nov 6 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: